Healthcare is moving beyond fascination with AI and into a far more consequential phase. AI was everywhere at HIMSS26, but the conversation shifted decisively from promise to preparedness. Speakers, vendors, and attendees spent less time debating what is possible and more time confronting what is scalable, governable, and culturally sustainable. The most important signals were not headline‑grabbing product launches, but uncomfortable truths about execution gaps, consumer accountability, and organizational drag that continue to slow meaningful transformation.
Top Takeaways: AI Meets The Income Statement
It’s no surprise that we saw more attention paid to the bottom line. The healthcare cost conundrum, exacerbated by tougher coverage dynamics, has left the industry wondering whether it can turn a profit. We saw greater emphasis on how advanced technology will help promote both better health and financial outcomes:
AI now has to prove operational value. Across the show floor, vendors emphasized fewer moonshots and more embedded, workflow‑level use cases. Epic previewed its Agent Factory to let health systems build, deploy, and monitor AI agents directly inside the EHR, while Microsoft expanded Dragon Copilot into a broader platform that unifies clinical, operational, and revenue cycle intelligence across partner ecosystems. The subtext across demos was consistent: AI must work inside existing — not alongside — systems, and it must demonstrate value beyond incremental productivity gains.
Agentic AI, especially for the back office, dominated the narrative. Conversations shifted from copilots to autonomous execution. Revenue cycle leaders gravitated toward agentic AI platforms positioned to manage denials, coding, and appeals with limited human intervention. FinThrive’s Fusion platform and Innovaccer’s Flow Capture stood out by framing AI as an operating model rather than a feature. Early adopters of their technology point to recovered revenue and expanded coder capacity as near-term benefits.
Governance and security emerged as true scaling constraints. As agentic capabilities expand, governance discussions struggle to keep pace. Sessions and informal conversations repeatedly surfaced concerns around accountability, enterprisewide efforts on understanding how AI is capable of making decisions, non‑human identity management, and post‑deployment monitoring. HCO leaders emphasized the need for continuous oversight as AI systems evolve in live clinical and financial settings. Many HCOs are deploying AI faster than they can validate, monitor, or govern it.
Affordability pressure is pushing AI toward RCM tools. Revenue cycle management quietly resurfaced as one of the few areas where AI enthusiasm aligned with board‑level urgency. As benefit complexity and patient responsibility increase and health systems stay close to their tech budgets, leaders increasingly described financial experience as inseparable from access and outcomes. AI‑driven payment integrity, prior authorization automation, and patient financial communications were among the most consistently cited use cases tied to measurable ROI.
Gaps In The Narrative: Accountability And Regulatory Risks Were Left Unexamined
Elements of an effective technology strategy were missing. The consumer, the regulator, and the employee seemed conspicuously absent from the conversation:
Clear ownership for consumer empowerment was missing. Consumer experience came up frequently in sessions, but accountability rarely did. Even though Amazon’s Health AI enables consumers to initiate care outside provider channels, few HCO leaders articulated who owns transparency, predictability, and affordability across fragmented journeys.
Attendees quietly acknowledged an honest, public reckoning with regulatory drag. While many leaders privately acknowledged that regulatory volatility is slowing transformation, public sessions largely avoided the topic. Payer rule changes, AI oversight ambiguity, and compliance uncertainty were cited as reasons pilots stall, yet few leaders offered concrete strategies on how to operate as goals shift. Their hushed tones reinforced their risk aversion rather than their adaptive execution.
Workforce disruption from agentic AI went largely unaddressed. Vendors highlighted automation gains, but spent little time on role redesign, training, or trust in hybrid human‑agent environments. There is a growing concern that validation, clinician involvement, and patient testing are lagging behind deployment speed, raising questions about long‑term adoption and safety.
Shared security accountability remained vague. HCO leaders frequently cited security as a priority yet expressed frustration that vendor assurances often stop at compliance checklists. As vendors gain broader access across clinical and financial systems, HCOs are increasingly demanding clearer contractual accountability, auditability, and enforcement mechanisms that few vendors clearly articulated.
What This Means For Healthcare Leaders
Leaders in the healthcare industry will have to focus on three areas touching operations, consumers, and finances:
Execution capability is now the competitive differentiator, not AI ambition. HIMSS 2026 signaled that most HCOs now have access to similar AI tools, platforms, and vendors. The advantage will no longer come from adopting AI first, but from executing better once it is live. Leaders who can standardize workflows, enforce decision rights, and sustain performance over time will pull ahead of peers still trapped in pilots, exceptions, and one‑off deployments. In this next phase, operational maturity will matter more than technological sophistication.
Predictability, not novelty, will shape consumer trust. The absence of clear ownership for consumer empowerment suggests many HCOs still conflate engagement with progress. What consumers increasingly value is not more digital touchpoints, but fewer surprises in healthcare cost, access, and outcomes. This reframes AI and digital strategy as a reliability problem, not an experience design problem. HCOs that can make journeys more predictable will earn trust even without flashy innovation.
Financial pressure will quietly determine which AI initiatives survive. The renewed focus on financial experience signals a broader reality: affordability is becoming the forcing function for operational change. AI initiatives that demonstrably reduce friction, prevent leakage, or improve cash flow will continue even amid uncertainty. Those tied only to long‑term transformation narratives will struggle for sponsorship. Leaders should expect capital to follow measurable operational impact, not vision alone.
Get In Touch With An Analyst
We’d love to hear your takeaways and thoughts on the event and key announcements. Forrester clients can schedule time with us here. Not a client? Learn more about how you can have Forrester on your side and by your side.
